The Effect of Saffron on Depression among Recovered Consumers of Methamphetamine Living with HIV/AIDS

被引:15
作者
Jalali, Farzad [1 ]
Hashemi, Seyedeh Fatemeh [1 ]
机构
[1] Negahe Mosbat Social Hlth Inst, Res Ctr, Tarbiat Sq,Moalem St, Mashhad, Iran
关键词
Depression; saffron; methamphetamine; HIV; AIDS; CROCUS-SATIVUS L; TO-MODERATE DEPRESSION; INJECTION-DRUG USERS; DOUBLE-BLIND; HIV-INFECTION; DISORDERS; CONSTITUENT; OUTCOMES;
D O I
10.1080/10826084.2018.1447583
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: From one hand, depression is one of the symptoms that occur after abstinence from methamphetamine. On the other people living with HIV/AIDS are in isolation due to the nature of their illness and depression is one of the most common mental health problems they experience. Objectives: This study was aimed at determining the effectiveness of saffron on reducing depression among recovered consumers of methamphetamine living with HIV/AIDS. Methods: The design of this study was semi-experimental with pre-test, post-test and control (placebo) groups. The statistical population consisted of all recovered consumers of methamphetamine living with HIV/AIDS who were referred to the Positive Club. Fifty-seven (57) recovered consumers of methamphetamine, living with HIV/AIDS, were selected by convenience sampling method. They were randomly assigned to an experimental (saffron) group and a control (placebo) group. The experimental group received 30ml of saffron per day for 8weeks, whereas the control (placebo) group received placebo the same way. BDI-II was used in this study as a measurement instrument. ANCOVA models were used for statistical inference. Results: The findings showed that saffron and its ingredients had been effective in reducing depression among this group (P < 0.05). Conclusion: In fact, saffron with its active ingredients (Crusin and Saffranal) by serotonin and dopamine secretion in the brain, help in reducing depression among recovered consumers of methamphetamine living with HIV/AIDS.
引用
收藏
页码:1951 / 1957
页数:7
相关论文
共 55 条
[1]   HIV/AIDS risk behaviors and correlates of injection drug use among drug users in Pakistan [J].
Ahmed, MA ;
Zafar, T ;
Brahmbhatt, H ;
Imam, G ;
ul Hassan, S ;
Bareta, JC ;
Strathdee, SA .
JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, 2003, 80 (02) :321-329
[2]   Crocus sativus L. in the treatment of mild to moderate depression:: A double-blind, randomized and placebo-controlled trial [J].
Akhondzadeh, S ;
Tahmacebi-Pour, N ;
Noorbala, AA ;
Amini, H ;
Fallah-Pour, H ;
Jamshidi, AH ;
Khani, M .
PHYTOTHERAPY RESEARCH, 2005, 19 (02) :148-151
[3]   Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: A pilot double-blind randomized trial [ISRCTN45683816] [J].
Akhondzadeh S. ;
Fallah-Pour H. ;
Afkham K. ;
Jamshidi A.-H. ;
Khalighi-Cigaroudi F. .
BMC Complementary and Alternative Medicine, 4 (1)
[4]   Heroin and Methamphetamine Injection: An Emerging Drug Use Pattern [J].
Al-Tayyib, Alia ;
Koester, Stephen ;
Langegger, Sig ;
Raville, Lisa .
SUBSTANCE USE & MISUSE, 2017, 52 (08) :1051-1058
[5]   Management of psychiatric disorders in patients infected with human immunodeficiency virus [J].
Angelino, AF ;
Treisman, GJ .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (06) :847-856
[6]  
Beck A, 2009, Bdi-ii manual
[7]   Selective Serotonin Reuptake Inhibitor Suppression of HIV Infectivity and Replication [J].
Benton, Tami ;
Lynch, Kevin ;
Dube, Benoit ;
Gettes, David R. ;
Tustin, Nancy B. ;
Lai, Jian Ping ;
Metzger, David S. ;
Blume, Joshua ;
Douglas, Steven D. ;
Evans, Dwight L. .
PSYCHOSOMATIC MEDICINE, 2010, 72 (09) :925-932
[8]   Differences between methamphetamine users and cocaine users in treatment [J].
Copeland, AL ;
Sorensen, JL .
DRUG AND ALCOHOL DEPENDENCE, 2001, 62 (01) :91-95
[9]   BLOOD-BORNE VIRUS-INFECTIONS AMONG AUSTRALIAN INJECTING DRUG-USERS - IMPLICATIONS FOR SPREAD OF HIV [J].
CROFTS, N ;
HOPPER, JL ;
MILNER, R ;
BRESCHKIN, AM ;
BOWDEN, DS ;
LOCARNINI, SA .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1994, 10 (06) :687-694
[10]  
Cryan JF, 2000, J PHARMACOL EXP THER, V295, P1120